1,216
Views
1
CrossRef citations to date
0
Altmetric
Diagnosis

Differences in diagnostic patterns of obstructive airway disease between areas and sex in Sweden and Finland - the Nordic EpiLung study

, RN, PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , MD, PhDORCID Icon, , MD, PhD, , MD, PhD, , PhD, , MD, PhD, , MD, PhD, , MSc, , MD, PhDORCID Icon, , MD, , MD, PhD & , RN, PhD show all
Pages 1196-1207 | Received 01 Feb 2020, Accepted 26 May 2020, Published online: 13 Jun 2020

References

  • Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414–1422. doi:10.1056/NEJMoa022363.
  • Barraclough R, Devereux G, Hendrick DJ, Stenton SC. Apparent but not real increase in asthma prevalence during the 1990s. Eur Respir J. 2002;20(4):826–833. doi:10.1183/09031936.02.00822002.
  • Lundbäck B, Rönmark E, Jonsson E, Larsson K, Sandström T. Incidence of physician-diagnosed asthma in adults-a real incidence or a result of increased awareness? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2001;95(8):685–692. doi:10.1053/rmed.2001.1126.
  • Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65(2):152–167. doi:10.1111/j.1398-9995.2009.02244.x.
  • To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi:10.1186/1471-2458-12-204.
  • Burney P, Chinn S, Jarvis D, Luczynska C, Lai E. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1996;9(4):687–695.
  • Backman H, Räisänen P, Hedman L, Stridsman C, Andersson M, Lindberg A, Lundbäck B, Rönmark E. Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys. Clin Exp Allergy. 2017;47(11):1426–1435. doi:10.1111/cea.12963.
  • Ekerljung L, Andersson A, Sundblad B-M, Rönmark E, Larsson K, Ahlstedt S, Dahlén S-E, Lundbäck B. Has the increase in the prevalence of asthma and respiratory symptoms reached a plateau in Stockholm, Sweden? Int J Tuberc Lung Dis. 2010;14(6):764–771.
  • Kainu A, Pallasaho P, Piirilä P, Lindqvist A, Sovijärvi A, Pietinalho A. Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Prim Care Respir J. 2013;22(1):64–71. doi:10.4104/pcrj.2013.00002.
  • Lötvall J, Ekerljung L, Rönmark EP, Wennergren G, Lindén A, Rönmark E, Torén K, Lundbäck B. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94. doi:10.1186/1465-9921-10-94.
  • Hisinger-Mölkänen H, Pallasaho P, Haahtela T, Lindqvist A, Sovijärvi A, Piirilä P. The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland. Respir Med. 2019;155:121–126. doi:10.1016/j.rmed.2019.07.014.
  • Haahtela T, Lehtimäki L, Ahonen E, Harju T, Jartti T, Kankaanranta H, Korhonen K, Mäkelä M, Puurunen M, Sovijärvi A, et al. Update on current care guidelines: asthma. Duodecim. 2013;129(9):994–995.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: http://www.ginasthma.org.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2019. Available from: http://www.goldcopd.org.
  • Heffler E, Crimi C, Mancuso S, Campisi R, Puggioni F, Brussino L, Crimi N. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48–52. doi:10.1016/j.rmed.2018.07.015.
  • José B. P d S, Camargos PAM, Cruz Filho Á. A S d, Corrêa R. d A. Diagnostic accuracy of respiratory diseases in primary health units. Rev Assoc Med Bras (1992)). 2014;60(6):599–612. doi:10.1590/1806-9282.60.06.021.
  • Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43(1):75–80. doi:10.1080/02770900500448738.
  • Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Akbari K, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535.
  • Lindberg A, Bjerg A, Bjerg-Bäcklund A, Rönmark E, Larsson L-G, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006;100(2):264–272. doi:10.1016/j.rmed.2005.04.029.
  • Kotaniemi J-T, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD. 2005;2(3):331–339. doi:10.1080/15412550500218122.
  • Sator L, Horner A, Studnicka M, Lamprecht B, Kaiser B, McBurnie MA, Buist AS, Gnatiuc L, Mannino DM, Janson C, et al. Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD analysis. Chest. 2019;156(2):277–288. doi:10.1016/j.chest.2019.01.015.
  • Melbye H, Drivenes E, Dalbak LG, Leinan T, Høegh-Henrichsen S, Østrem A. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis. 2011;6:597–603.
  • Vasankari T, Pietinalho A, Lertola K, Junnila SY, Liippo K. Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme. BMC Fam Pract. 2011;12(1):97. doi:10.1186/1471-2296-12-97.
  • Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05-020415.
  • Backman H, Eriksson B, Rönmark E, Hedman L, Stridsman C, Jansson S-A, Lindberg A, Lundbäck B. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–110. doi:10.1016/j.rmed.2016.03.013.
  • Kainu A, Pallasaho P, Pietinalho A. No change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults - a report from the FinEsS Helsinki Study. Eur Clin Respir J. 2016;3(1):31780. doi:10.3402/ecrj.v3.31780.
  • Axelsson M, Lindberg A, Kainu A, Rönmark E, Jansson SA. Respiratory symptoms increase health care consumption and affect everyday life - a cross-sectional population-based study from Finland, Estonia, and Sweden. Eur Clin Respir J. 2016;3:31024. doi:10.3402/ecrj.v3.31024.
  • Grønseth R, Vollmer WM, Hardie JA, Ólafsdóttir IS, Lamprecht B, Buist AS, Gnatiuc L, Gulsvik A, Johannessen A, Enright P, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–1620. doi:10.1183/09031936.00036813.
  • Maio S, Baldacci S, Carrozzi L, Pistelli F, Angino A, Simoni M, Sarno G, Cerrai S, Martini F, Fresta M, et al. Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study. Respir Med. 2016;110:58–65. doi:10.1016/j.rmed.2015.11.006.
  • Wheaton AG, Ford ES, Thompson WW, Greenlund KJ, Presley-Cantrell LR, Croft JB. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States–National Health and Nutrition Examination Survey 2007–2010. BMC Public Health. 2013;13(1):854. doi:10.1186/1471-2458-13-854.
  • Axelsson M, Ekerljung L, Eriksson J, Hagstad S, Rönmark E, Lötvall J, Lundbäck B. Chronic bronchitis in West Sweden - a matter of smoking and social class. Eur Clin Respir J. 2016;3:30319doi:10.3402/ecrj.v3.30319.
  • Soriano JB, Ancochea J, Miravitlles M, Garcia-Rio F, Duran-Tauleria E, Munoz L, Jimenez-Ruiz CA, Masa JF, Viejo JL, Villasante C, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010;36(4):758–765. doi:10.1183/09031936.00138409.
  • Bhatta L, Leivseth L, Mai X-M, Chen Y, Henriksen AH, Langhammer A, Brumpton BM. Prevalence and trend of COPD from 1995-1997 to 2006-2008: the HUNT study, Norway. Respir Med. 2018;138:50–56. doi:10.1016/j.rmed.2018.03.020.
  • Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, Ichinose M, Aisanov Z, Oh Y-M, Davis KJ, et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611. doi:10.2147/COPD.S61854.
  • Vasankari TM, Impivaara O, Heliövaara M, Heistaro S, Liippo K, Puukka P, Saarelainen S, Kanervisto M, Jousilahti P. No increase in the prevalence of COPD in two decades. Eur Respir J. 2010;36(4):766–773. doi:10.1183/09031936.00178109.
  • Pallasaho P, Meren M, Raukas-Kivioja A, Rönmark E. Different labelling of obstructive airway diseases in Estonia, Finland, and Sweden. Eur J Epidemiol. 2005;20(12):975–983. doi:10.1007/s10654-005-4117-6.
  • Jannus-Pruljan L, Meren M, Polluste J, Loit HM, Kiviloog J, Baburin A, et al. Postal survey on asthma, chronic bronchitis and respiratory symptoms among adult Estonians and non-Estonians (FinEsS-study). Eur J Public Health. 2004;14(2):114–119. doi:10.1093/eurpub/14.2.114.
  • Meren M, Raukas-Kivioja A, Jannus-Pruljan L, Loit HM, Rönmark E, Lundbäck B. Low prevalence of asthma in westernizing countries-myth or reality? Prevalence of asthma in Estonia-a report from the "FinEsS" study“”. J Asthma. 2005;42(5):357–365. doi:10.1081/JAS-62985.
  • Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit HM, Larsson K, Laitinen LA. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med. 2002;96(10):759–769. doi:10.1053/rmed.2002.1308.
  • Honkamäki J, Hisinger-Mölkänen H, Ilmarinen P, Piirilä P, Tuomisto LE, Andersén H, Huhtala H, Sovijärvi A, Backman H, Lundbäck B, et al. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood. Respir Med. 2019;154:56–62. doi:10.1016/j.rmed.2019.06.003.
  • Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J. 1991;4(3):257–266.
  • Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581.
  • SPSS IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.
  • Chi-Square Test Calculator. 2018. Avaliable from: https://www.socscistatistics.com/tests/chisquare2/Default2.aspx.
  • Council of the European Union, European Parliament. General Data Protection Regulation. The Regulation (EU) 2016/679.
  • National guidelines for treatment of asthma and COPD. The National Board of Health and Welfare. 2015. https://www.socialstyrelsen.se/publikationer2018/2018-1-36.
  • Kankaanranta H, Tuomisto LE, Ilmarinen P. Age-specific incidence of new asthma diagnoses in Finland. J Allergy Clin Immunol Pract. 2017;5(1):189–191.e3. doi:10.1016/j.jaip.2016.08.015.
  • Pignataro FS, Bonini M, Forgione A, Melandri S, Usmani OS. Asthma and gender: The female lung. Pharmacol Res. 2017;119:384–390. doi:10.1016/j.phrs.2017.02.017.
  • McCallister JW, Mastronarde JG. Sex differences in asthma. J Asthma. 2008;45(10):853–861. doi:10.1080/02770900802444187.
  • Annesi-Maesano I, Lundbäck B, Viegi G (editors). ERS Monograph. Respiratory Epidemiology. 2014. doi:10.1183/2312508X.10008514.
  • Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–218. doi:10.1016/j.trsl.2013.04.003.
  • Sawalha S, Hedman L, Rönmark E, Lundbäck B, Lindberg A. Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study. COPD. 2017;12:1269–1277. doi:10.2147/COPD.S127923.
  • Ekerljung L, Rönmark E, Lötvall J, Wennergren G, Torén K, Lundbäck B. Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort. Clin Respir J. 2013;7(1):53–63. doi:10.1111/j.1752-699X.2012.00281.x.
  • Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643–653. doi:10.1016/j.annepidem.2007.03.013.
  • Rönmark EP, Ekerljung L, Lötvall J, Toren K, Rönmark E, Lundbäck B. Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir Med. 2009;103(12):1807–1815. doi:10.1016/j.rmed.2009.07.014.